EIGR - Eiger BioPharmaceuticals, Inc.
Close
1.725
-0.175 -10.145%
Share volume: 137,824
Last Updated: Wed 10 Apr 2024 10:00:00 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
-1.15%
PREVIOUS CLOSE
CHG
CHG%
$1.90
-0.18
-9.21%
Summary score
41%
Profitability
50%
Dept financing
18%
Liquidity
69%
Performance
30%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Long-term ratios 30-Sep-2019 - 30-Sep-2023
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
38.88%
Return on assets
-16.76%
Return on sales
-638.12%
Return on invested capital
89.14%
Total debt ratio
47.83%
Debt ratio change over timeo
-0.7%
Current Ratio
5.67%
Quick Ratio
5.49%
Cash Position Ratio
4.48%
Short-term ratios 30-Sep-2022 - 30-Sep-2023
The data are presented for the financials results of the quarters of the last year.
Return on equity
219.66%
Return on assets
-25.21%
Return on sales
-601.54%
Return on invested capital
118.14%
Total debt ratio
75.05%
Debt ratio change over timeo
-0.33%
Current Ratio
4.06%
Quick Ratio
3.94%
Cash Position Ratio
3.17%
Last quarter ratios 30-Sep-2023
The data are presented for the financials results of the last quarter.
Return on equity
1124.06%
Return on assets
-30.42%
Return on sales
-527.52%
Return on invested capital
116.37%
Total debt ratio
102.88%
Debt ratio change over time
0.04%
Current Ratio
3.31%
Quick Ratio
3.24%
Cash Position Ratio
2.39%
Performance ratios (change over 4 years) 30-Sep-2019 - 30-Sep-2023
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-53.17%
Return on assets
-110.26%
Return on sales
-426.69%
Return on invested capital
8.62%
Total debt ratio
-70.44%
Debt ratio change over time
-0.7%
Current Ratio
0.77%
Quick Ratio
0.29%
Cash Position Ratio
0.09%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | EIGR | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | 38.88% | 7.58% | 36.15% | 7.75% |
| Return on assets | -16.76% | 2.95% | 3.44% | 5.85% |
| Return on sales | -638.12% | 30.63% | 35.3% | 41.32% |
| Return on invested capital | 89.14% | 3.7% | 6.05% | 20.44% |
| Profitability | 50% | 37% | 61% | 61% |
| Total debt ratio | 47.83% | 92.36% | 89.3% | 27.07% |
| Debt ratio change over time | -0.7% | 292.67% | 15.45% | 1.02% |
| Dept financing | 13% | 50% | 25% | 7% |
| Current Ratio | 4.06% | 0.94% | 2.55% | 5.29% |
| Quick Ratio | 3.94% | 0.82% | 2.23% | 4.52% |
| Cash Position Ratio | 3.17% | 0.3% | 1.72% | 2.75% |
| Liquididy | 75% | 13% | 21% | 46% |
| Short-term ratios | EIGR | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | 219.66% | 11.57% | 35.05% | 4.21% |
| Return on assets | -25.21% | 2.86% | 2.7% | 3.6% |
| Return on sales | -601.54% | 27.99% | 31.88% | 33.53% |
| Return on invested capital | 118.14% | 2.16% | 6.93% | 9.79% |
| Profitability | 50% | 43% | 48% | 53% |
| Total debt ratio | 75.05% | 89.83% | 93.1% | 22.12% |
| Debt ratio change over time | -0.33% | 102.83% | 13.09% | 1.3% |
| Dept financing | 20% | 49% | 28% | 6% |
| Current Ratio | 4.06% | 0.94% | 2.55% | 5.29% |
| Quick Ratio | 3.94% | 0.82% | 2.23% | 4.52% |
| Cash Position Ratio | 3.17% | 0.3% | 1.72% | 2.75% |
| Liquididy | 66% | 11% | 38% | 72% |